v3.26.3
SCHEDULE OF DEFERRED TAX ASSETS NET (Details) - USD ($)
Jul. 31, 2026
Jul. 31, 2025
Income Tax Disclosure [Abstract]    
Property and equipment $ 731 $ 730
Marketable securities 11,758 11,760
Intellectual property 260,860
Warrant liability
Share issuance costs 688,831 310,230
Investment in BC Therapeutics 67,766 44,650
Operating tax losses carried forward 5,674,627 5,067,840
Operating tax losses carried forward - USA 14,921,914 8,494,300
Research and development 14,016,183 14,240,640
Total deferred tax assets 35,381,810 28,431,010
Valuation allowance (35,075,129) (24,329,720)
Net deferred tax assets 306,681 4,101,290
Warrant liability (43,272) (4,053,520)
Intellectual property (206,654)
Property, plant, and equipment (56,755) (47,770)
Total net deferred tax liabilities (306,681) (4,101,290)
Net deferred tax assets (liabilities)